AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts-Reference-Cited by-同舟云学术

AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts

Published:2023-11 Issue: Volume:134 Page:107376
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Zhao Davidson^ORCID,Zhou Qianghua^ORCID,Zarif Mojgan,Eladl Entsar^ORCID,Wei Cuihong,Atenafu Eshetu G.,Schuh Andre,Tierens Anne,Yeung Yu Wing Tony,Minden Mark D.,Chang Hong^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. Su L., Shi Y.Y., Liu Z.Y., Gao S.J. Acute myeloid leukemia with CEBPA mutations: current progress and future directions. Front. Oncol. [Internet]. 2022 Feb 1 [cited 2023 Apr 12];12. Available from: 〈https://pubmed.ncbi.nlm.nih.gov/35178345/〉.

2. Ohlsson E., Schuster M.B., Hasemann M., Porse B.T. The multifaceted functions of C/EBPα in normal and malignant haematopoiesis. Leukemia [Internet]. 2016 Apr 1 [cited 2023 Apr 12];30(4):767–75. Available from: 〈https://pubmed.ncbi.nlm.nih.gov/26601784/〉.

3. Wouters B.J., Löwenberg B., Erpelinck-Verschueren C.A.J., Van Putten W.L.J., Valk P.J.M., Delwel R. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood [Internet]. 2009 Mar 26 [cited 2023 May 27];113(13):3088–91. Available from: 〈https://pubmed.ncbi.nlm.nih.gov/19171880/〉.

4. Pabst T., Eyholzer M., Fos J., Mueller B.U. Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis. Br. J. Cancer [Internet]. 2009 Apr 21 [cited 2023 May 27];100(8):1343–6. Available from: 〈https://pubmed.ncbi.nlm.nih.gov/19277035/〉.

5. Green C.L., Koo K.K., Hills R.K., Burnett A.K., Linch D.C., Gale R.E. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. J. Clin. Oncol. [Internet]. 2010 Jun 1 [cited 2023 May 27];28(16):2739–47. Available from: 〈https://pubmed.ncbi.nlm.nih.gov/20439648/〉.